is manjaro a glp-1 Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN GLP-1 receptor agonists | How
Description
Depending on the individual, drug, and dosage, GLP-1 nausea can be persistent or infrequent, mild or severe

In addition, glucagon may contribute, at least partly, to the development of diabetic cardiomyopathy, as antagonism of the GCGR reduced its incidence in a mouse model of diabetes over several months (Sharma et al

always use the product and dose your clinician has prescribed

Antiatherosclerotic effects of sodium-glucose cotransporter 2 inhibitors: an underrecognized piece of the big puzzle

The result was a significant reduction in GLP-1 production, decreased insulin secretion, and elevated postprandial blood glucose
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
The short answer is that theres no scientific evidence showing that they lead to weight loss
